Add Company
Join Now

Hopewell Therapeutics Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Hopewell Therapeutics's estimated annual revenue is currently $542.5k per year.(i)
  • Hopewell Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Hopewell Therapeutics has 7 Employees.(i)
  • Hopewell Therapeutics grew their employee count by -53% last year.

Hopewell Therapeutics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Director Discovery BiologyReveal Email/Phone
6
Scientist II- Preclinical group leaderReveal Email/Phone
7
Sr. ScientistReveal Email/Phone
8
Scientist II- Preclinical group leaderReveal Email/Phone
9
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Hopewell Therapeutics?

Hopewell is a privately held biotechnology company based in Woburn, Massachusetts.It was founded by Dr. Qiaobing Xu, Professor of Biomedical Engineering at Tufts University and a world-renowned leader in the application of material science engineering to biomedicine, with a focus on advancing the field of genomic medicine with leading-edge lipid nanoparticle (LNP) delivery technology. The company established operations with a seed financing round in January 2022.Leveraging an extensive intellectual property portfolio licensed from Tufts and augmented at Hopewell, the company specializes in synthesizing and developing targeted, efficient, and safe LNPs supporting diverse cargoes to address unmet medical needs through its differentiated ATLAS platform. Hopewell’s LNP platform serves as an engine for both internal pipeline programs and external collaborations. With a fully operational lab and an experienced team, Hopewell has established broad R&D capabilities spanning lipid synthesis, mRNA cargo development, and LNP development.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$542.5k

Revenue (est)

-53%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M7-22%N/A
#2
$1.1M70%N/A
#3
$1.1M70%N/A
#4
$1.1M70%N/A
#5
$0.6M80%N/A